Target intelligence / Profile preview

Microbial pathogens and viral particles

Molecular classification
Other
01

Overview

Microbial pathogens and viral particles are biological entities, including bacteria, viruses, fungi, and protozoa, that can cause infectious diseases in humans and other hosts (NIH, 2023). These agents function by invading host tissues, utilizing host resources for replication, and often producing toxins or triggering harmful immune responses (StatPearls, 2023). In the context of pharmacology, these are not single molecular targets but rather complex organisms or particles containing numerous potential drug targets such as enzymes, structural proteins, and nucleic acids (Nature Reviews Drug Discovery, 2013). Drugs interacting with these entities include antibiotics, antivirals, and antifungals, which work through diverse mechanisms like inhibiting cell wall synthesis or blocking viral entry (WHO, 2021). The primary therapeutic challenge associated with these pathogens is the emergence of antimicrobial resistance, which renders existing treatments ineffective and necessitates the continuous development of new therapeutic strategies (CDC, 2022). Furthermore, targeting these agents often requires balancing efficacy against the pathogen with the preservation of the host's beneficial commensal microbiota (Nature, 2018). Modern approaches also include the use of vaccines to prime the immune system to recognize and neutralize these particles before an infection becomes established (Mayo Clinic, 2023).

Other names
Infectious agentsMicrobesPathogenic microorganismsVirionsGerms
02

Mechanism of action

Inhibition of cell wall synthesis, inhibition of nucleic acid replication, inhibition of protein synthesis, disruption of cell membrane integrity, and inhibition of viral entry or release.

03

Biological functions

PathogenesisReplicationInfectionHost colonizationToxin production
04

Disease associations

InfectionSepsisPneumoniaMeningitisGastroenteritis
05

Safety considerations

Antimicrobial resistance (AMR)Disruption of the commensal microbiomeSystemic toxicityHypersensitivity reactionsJarisch-Herxheimer reaction
06

Interacting drugs

Penicillin

4 more in the full profile.

07

Biomarkers

Pathogen-specific DNA/RNASurface antigensC-reactive protein (CRP)ProcalcitoninAntibody titers

Beyond the preview

Go deeper on Microbial pathogens and viral particles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial pathogens and viral particles.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call